UNSPSC 51294423: Vortioxetine

A drug indicated for the treatment of major depressive disorder.

UNSPSC 51294423 Vortioxetine, a Commodity code, nominally covers a specific pharmaceutical product, but recent state and local solicitations under this code do not align with its stated scope. Seminole County, Florida's IFB60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, solicits naloxone and safe drug deactivation systems—opioid-reversal medication and harm-reduction equipment—rather than vortioxetine, an antidepressant. The mismatch suggests either a cataloging error in the county's procurement system or that the code has been applied inconsistently to cover a broader range of pharmaceutical and medical products than the code name reflects. The solicitation requires annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and mandates that vendors cover all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, comply with E-Verify requirements, and meet federal environmental compliance standards given potential FEMA funding.

The recent-opportunities block contains only one state and local posting, Seminole County's naloxone and drug deactivation procurement. Geographic activity under this code appears limited to Florida based on available records. No other issuing bodies or jurisdictions surface in the recent data, and no pattern of repeat buyers emerges. The code shows minimal recent state and local procurement activity, and the single posted opportunity diverges sharply from the code's pharmaceutical product name, limiting the utility of this code as a targeting criterion for naloxone or vortioxetine procurement until the cataloging issue is clarified.